Entrada Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Entrada Therapeutics Inc
TickerTRDA
CIK #0001689375
CUSIP29384C108
SectorLife Sciences - Pharmaceutical Preparations
Address6 Tide Street, Boston, MA 02210
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Entrada Therapeutics Inc 2021-04-13 116.2 M Exemption: 506(b) · Duration: One year or less · Revenue: Decline to Disclose
Cycloporters Inc 2016-11-10 0.6 M Exemption: 506(b) · Remaining: $999,999 · Duration: One year or less · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001689375] 10-K
[0001689375] 10-Q
[0001689375] 3
[0001689375] 4
[0001689375] 8-K
[0001689375] D
[0001689375] SC 13D
[0001689375] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
TCG Crossover GP I LLC Entrada Therapeutics Inc [2025-11-25] 0.0
Janus Henderson Group PLC Entrada Therapeutics Inc [2025-02-14] 0.0
BlackRock Inc Entrada Therapeutics Inc [2025-02-04] 0.0
Price T Rowe Associates Inc /MD/ Entrada Therapeutics Inc [2022-02-14] 6.4
Redmile Group LLC Entrada Therapeutics Inc [2022-02-14] 6.3
Roche Finance Ltd Entrada Therapeutics Inc [2022-02-14] 9.0
MRL Ventures Fund LLC Entrada Therapeutics Inc [2022-02-08] 5.6
Wellington Management Group LLP Entrada Therapeutics Inc [2022-02-04] 0.98
Baker Bros Advisors LP Entrada Therapeutics Inc [2021-12-16] 15.1
5AM Ventures V LP Entrada Therapeutics Inc [2021-11-12] 11.0
MPM BioVentures 2014 LP Entrada Therapeutics Inc [2021-11-12] 6.7
Baker Bros Advisors LP Entrada Therapeutics Inc [2021-11-10] 15.1
Form 3/4/5 Filer 2011 - 2026
Entrada Therapeutics Inc
Radhakrishnan Maha
Parmar Kush
Kim Peter S
Chapman Gina
Thistle Mary
Zeiher Bernhardt G
Sethuraman Natarajan
Dowden Nathan J
Wentworth KORY James
Doshi Dipal
Baker Bros Advisors GP LLC
Baker Julian
Baker Felix
Baker Bros Advisors LP
5AM Opportunities I GP LLC
5AM Ventures V LP
5AM Opportunities I LP
Schwab Andrew J
5AM Partners V LLC
Rocklage Scott M
MPM BioVentures 2018 LP
MPM BioVentures 2018 GP LLC
MPM BioVentures 2018 LLC
MPM BioVentures 2014 LP
MPM BioVentures 2014 GP LLC
Foley Todd
MPM BioVentures 2018 B LP
Evnin Luke
MPM Asset Management Investors BV2014 LLC
MPM BioVentures 2014 LLC
MPM Asset Management Investors BV2018 LLC
Gadicke Ansbert
MPM BioVentures 2014 B LP
Kreher Nerissa
Crowley John F
Nuechterlein Carole
Roche Holding Ltd
Roche Finance Ltd
Redmile Group LLC
Redmile Biopharma Investments III LP
Green Jeremy
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Wentworth KORY James
Common Stock
2026-03-10 Sell 11,388 $13.02 148,272
Dowden Nathan J
Common Stock
2026-03-10 Sell 11,894 $13.05 155,217
Dowden Nathan J
Common Stock
2026-03-09 Sell 3,116 $13.02 40,570
Wentworth KORY James
Common Stock
2026-03-09 Sell 5,089 $13.00 66,157
Wentworth KORY James
Common Stock
2026-03-04 Sell 7,988 $12.25 97,853
Dowden Nathan J
Common Stock
2026-03-03 Tax withheld 14,038 $11.76 165,087
Doshi Dipal
Common Stock
2026-03-03 Tax withheld 19,181 $11.76 225,569
Wentworth KORY James
Common Stock
2026-03-03 Tax withheld 5,712 $11.76 67,173
Sethuraman Natarajan
Common Stock
2026-03-03 Tax withheld 7,577 $11.76 89,106
Wentworth KORY James
Common Stock
2026-03-02 Tax withheld 2,939 $11.66 34,269
Dowden Nathan J
Common Stock
2026-03-02 Tax withheld 7,223 $11.66 84,220
Doshi Dipal
Common Stock
2026-03-02 Tax withheld 9,869 $11.66 115,073
Sethuraman Natarajan
Common Stock
2026-03-02 Tax withheld 3,898 $11.66 45,451
Sethuraman Natarajan
Common Stock
2026-03-01 Grant 55,800 $0.00
Dowden Nathan J
Common Stock
2026-03-01 Grant 55,800 $0.00
Dowden Nathan J
Stock Option (Right to Buy) · derivative
2026-03-01 Grant 83,200 $0.00
Wentworth KORY James
Common Stock
2026-03-01 Grant 44,600 $0.00
Doshi Dipal
Common Stock
2026-03-01 Grant 139,400 $0.00
Wentworth KORY James
Stock Option (Right to Buy) · derivative
2026-03-01 Grant 66,600 $0.00
Doshi Dipal
Stock Option (Right to Buy) · derivative
2026-03-01 Grant 208,000 $0.00
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 119 25,149,386
2025-12-31 113 24,043,044
2025-09-30 116 28,507,670
2025-06-30 107 27,068,730
2025-03-31 111 27,541,629
2024-12-31 103 27,846,444
2024-09-30 99 27,147,961
2024-06-30 84 26,574,256
2024-03-31 78 23,511,081
2023-12-31 63 23,362,575
2023-09-30 56 23,062,073
2023-06-30 57 22,820,778
Form 13F Holdings
Firm Period DFND Voting Shares
Y-Intercept Hong Kong Ltd [2026-06-30] SOLE 34,687 34,687
Wealth Enhancement Advisory Services LLC [2026-06-30] SOLE 519 12,769
Versant Capital Management Inc [2026-06-30] SOLE 4,221 4,221
Gamma Investing LLC [2026-06-30] DFND 525 525
True Wealth Design LLC [2026-06-30] SOLE 0 307
MassMutual Private Wealth & Trust FSB [2026-06-30] SOLE 186 186
IFP Advisors LLC [2026-06-30] SOLE 171 171
Farther Finance Advisors LLC [2026-06-30] SOLE 0 143
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com